UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )

Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

 

Check the appropriate box:

 

☐

Preliminary Proxy Statement
   

☐

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
   

☐

Definitive Proxy Statement
   

☒

Definitive Additional Materials
   

☐

Soliciting Material under §240.14a-12

 

Zevra Therapeutics, Inc.

(Name of Registrant as Specified in its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

☒

No fee required
   

☐

Fee paid previously with preliminary materials
   

☐

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 
 

 

page1.jpg

 

 
 

 

page2.jpg

 

 
 

 

page3.jpg

 

 
 

 

page4.jpg

 

 
KemPharm (NASDAQ:KMPH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more KemPharm Charts.
KemPharm (NASDAQ:KMPH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more KemPharm Charts.